Practice of Controlled Temperature Chain (CTC) Technique during a Mass Vaccination Campaign in Côte d’Ivoire
作者： Damus Paquin Kouassi , Lépri Bernadin Nicaise Aka , Bi Vroh Joseph Bénié , Soplé Ruth Coulibaly , Dodji Blaise Tagodé
关键词: Cote d ivoire 、 Medicine 、 Mass vaccination 、 Vaccination 、 Demography 、 MenAfriVac 、 World health
摘要: Background: MenAfriVacTM is the first of World Health Organization (WHO)’s pre-qualified vaccines to be allowed mass vaccination campaign at a temperature below or equal 40°C during 4 days. This new practice has already been used in some African countries. article described opinion and use this technique by actors on field, Cote d’Ivoire, December 2014. Methods: We conducted crosssectional study CTC field their perception practice, 2 25 health districts Findings: As results, Seguela 98.25% respondents expressed favourable CTC, citing advantages such as vaccine carriers requiring no ice packs (29.2%), financial benefit (12.28%) lighter (5.26%). In Bouna, gave same in, respectively, 34%, 2% 8% cases. The peak total vials for immunization sessions reached 376 day one, then dropped 235 three 220 six. Discussion: Vaccinators found benefits related but they were cautious using technique.
i-scholar.in参考文章(10)
Maman S. Chaibou, Harouna Bako, Laouali Salisou, Téné M. Yaméogo, Mariama Sambo, Sung Hye Kim, Mamoudou H. Djingarey, Patrick L.F. Zuber, William A. Perea, Lorenzo Pezzoli, Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010. Vaccine. ,vol. 30, pp. 5229- 5234 ,(2012) , 10.1016/J.VACCINE.2012.06.006
Paul A Kristiansen, Absatou Ky Ba, Abdoul-Salam Ouédraogo, Idrissa Sanou, Rasmata Ouédraogo, Lassana Sangaré, Fabien Diomandé, Denis Kandolo, Inger Marie Saga, Lara Misegades, Thomas A Clark, Marie-Pierre Préziosi, Dominique A Caugant, Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac. BMC Infectious Diseases. ,vol. 14, pp. 663- 663 ,(2014) , 10.1186/S12879-014-0663-4
Claude-Roger Ouandaogo, Téné M. Yaméogo, Fabien V.K. Diomandé, Charles Sawadogo, Bassirou Ouédraogo, Rasmata Ouédraogo-Traoré, Lorenzo Pezzoli, Mamoudou H. Djingarey, Nehémie Mbakuliyemo, Patrick L.F. Zuber, Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine. ,vol. 30, ,(2012) , 10.1016/J.VACCINE.2011.12.112
Simona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, Laifoya Olodo, Sylvestre Tiendrebeogo, Olivier Ronveaux, Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine. ,vol. 32, pp. 1431- 1435 ,(2014) , 10.1016/J.VACCINE.2014.01.038
Saverio Caini, Nam Seon Beck, Harouna Yacouba, Idrissa Maiga, Ibrahim Chaibou, Ide Hinsa, Aboubacar Adakal, Aboubacar Issoufou, Sung Hye Kim, Lorenzo Pezzoli, From Agadez to Zinder: estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012. Vaccine. ,vol. 31, pp. 1597- 1603 ,(2013) , 10.1016/J.VACCINE.2013.01.015
Siddhivinayak Hirve, Ashish Bavdekar, Anand Pandit, Sanjay Juvekar, Malini Patil, Marie-Pierre Preziosi, Yuxiao Tang, Elisa Marchetti, Lionel Martellet, Helen Findlow, Cheryl Elie, Varsha Parulekar, Brian Plikaytis, Ray Borrow, George Carlone, Prasad S. Kulkarni, Akshay Goel, Karupothula Suresh, Suresh Beri, Subhash Kapre, Suresh Jadhav, Jean-Marie Preaud, Simonetta Viviani, F. Marc LaForce, Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial Vaccine. ,vol. 30, pp. 6456- 6460 ,(2012) , 10.1016/J.VACCINE.2012.08.004
Carl Frasch, Marie-Pierre Preziosi, F. Marc LaForce, Development of a group A meningococcal conjugate vaccine, MenAfriVacTM Human Vaccines & Immunotherapeutics. ,vol. 8, pp. 715- 724 ,(2012) , 10.4161/HV.19619
Mamoudou H. Djingarey, Rodrigue Barry, Mete Bonkoungou, Sylvestre Tiendrebeogo, Rene Sebgo, Denis Kandolo, Clement Lingani, Marie-Pierre Preziosi, Patrick L.F. Zuber, William Perea, Stéphane Hugonnet, Nora Dellepiane de Rey Tolve, Carole Tevi-Benissan, Thomas A. Clark, Leonard W. Mayer, Ryan Novak, Nancy E. Messonier, Monique Berlier, Desire Toboe, Deo Nshimirimana, Richard Mihigo, Teresa Aguado, Fabien Diomandé, Paul A. Kristiansen, Dominique A. Caugant, F. Marc LaForce, Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine. ,vol. 30, ,(2012) , 10.1016/J.VACCINE.2011.12.073
Patrick Lydon, Simona Zipursky, Carole Tevi-Benissan, Mamoudou Harouna Djingarey, Placide Gbedonou, Brahim Oumar Youssouf, Michel Zaffran, Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad Bulletin of The World Health Organization. ,vol. 92, pp. 86- 92 ,(2014) , 10.2471/BLT.13.123471
Stéphane Verguet, Waasila Jassat, Melanie Y Bertram, Stephen M Tollman, Christopher JL Murray, Dean T Jamison, Karen J Hofman, None, Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa Journal of Epidemiology and Community Health. ,vol. 67, pp. 947- 952 ,(2013) , 10.1136/JECH-2012-202216